New Study Reveals High Success Rate of Mendaera’s Focalist™ System in Diverse Medical Fields

Mendaera's Focalist™ System Achieves Remarkable Success in Clinical Study

Mendaera Inc., an innovative player in healthcare technology, recently announced significant findings from a peer-reviewed study examining its Focalist™ system. This system has garnered attention for its use across urology, anesthesiology, and nephrology. The results are indeed promising: the technical success rate reached an impressive 98%, with zero adverse events related to the device.

Study Overview

Conducted across 61 ultrasound-guided procedures, the study was innovative as it marked one of the first prospective evaluations of a handheld robotic system aimed at enhancing procedural precision in various medical specialties. It was published in the esteemed World Journal of Urology, expressing confidence in the potential of the Focalist system to increase both accessibility and consistency in these complex procedures.

Lead investigator Dr. Abhishek Singh praised the system's intuitive design. After just a single 45-minute training session, participating physicians reported high levels of ease in using the system, which employs a combination of handheld robotics, real-time imaging, and intelligent guidance software. Key features that stood out included trajectory planning and needle-depth tracking, which aid physicians in navigating challenging procedures.

Advantages of the Focalist™ System

The Focalist system was evaluated for three major procedural categories: organ access, pain management, and vascular access. Eleven physicians across urology, nephrology, and anesthesiology participated in the study. They noted that the Focalist system enabled real-time trajectory adjustments, which significantly improved their confidence and execution during needle placements. Dr. Singh elaborated on a critical struggle in ultrasound-guided procedures: translating visual data into precise needle movements, a skill that often requires extensive experience. The system’s real-time feedback made this task significantly easier, allowing physicians to perform procedures effectively, even as newcomers.

Mendaera developed this technology to bridge the gap in procedural care, which frequently relies on highly specialized skills that are not universally accessible among clinicians. According to Josh DeFonzo, co-founder and CEO, the Focalist system is paving the way toward democratizing high-quality minimally invasive care. He expressed hope that the widespread use of such technology could alleviate performance variability and improve overall patient outcomes.

Future of the Focalist™ System

Since achieving FDA clearance in July 2025, the Focalist system is now set to enter the commercial market in the United States. The recent study not only solidifies its capabilities but also enhances Mendaera's ambitions to expand the use of robotics in healthcare. Mendaera’s vision aims for healthcare professionals to conduct procedures with improved precision, ensuring better access to care for patients across the U.S.

In summary, the Focalist system represents an essential step toward enhancing procedural capabilities in medicine. The study's findings provide robust evidence that handheld robotics can significantly benefit diverse specialists. The movement towards utilizing advanced technology like the Focalist™ system showcases Mendaera's commitment to making quality healthcare more accessible.

For further details, the open-access study is available here.

With a strong backing from leading investors and an experienced leadership team, Mendaera is poised to be a frontrunner in the healthcare technology industry, revolutionizing how minimally invasive procedures are performed.